Victory Capital Management Inc. trimmed its holdings in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 26.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 17,994 shares of the technology company’s stock after selling 6,398 shares during the period. Victory Capital Management Inc.’s holdings in Simulations Plus were worth $1,294,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in SLP. BlackRock Inc. increased its stake in shares of Simulations Plus by 15.3% in the third quarter. BlackRock Inc. now owns 2,157,173 shares of the technology company’s stock worth $162,563,000 after acquiring an additional 285,977 shares during the period. State Street Corp raised its stake in shares of Simulations Plus by 8.5% during the 3rd quarter. State Street Corp now owns 512,208 shares of the technology company’s stock valued at $38,600,000 after buying an additional 39,938 shares during the last quarter. Conestoga Capital Advisors LLC lifted its holdings in shares of Simulations Plus by 869.6% in the 4th quarter. Conestoga Capital Advisors LLC now owns 237,611 shares of the technology company’s stock valued at $17,089,000 after buying an additional 213,106 shares during the period. Congress Asset Management Co. MA boosted its stake in shares of Simulations Plus by 2.3% in the fourth quarter. Congress Asset Management Co. MA now owns 196,992 shares of the technology company’s stock worth $14,168,000 after buying an additional 4,485 shares during the last quarter. Finally, Jennison Associates LLC acquired a new stake in Simulations Plus during the third quarter worth about $14,038,000. 60.75% of the stock is currently owned by institutional investors and hedge funds.

Simulations Plus stock opened at $71.92 on Tuesday. The company’s fifty day moving average price is $78.88 and its 200 day moving average price is $68.75. The stock has a market capitalization of $1.44 billion, a P/E ratio of 141.02, a P/E/G ratio of 8.45 and a beta of -0.07. Simulations Plus, Inc. has a 1 year low of $26.00 and a 1 year high of $90.92.

Simulations Plus (NASDAQ:SLP) last announced its earnings results on Sunday, January 10th. The technology company reported $0.12 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.11 by $0.01. Simulations Plus had a net margin of 22.74% and a return on equity of 10.65%. The business had revenue of $10.70 million for the quarter, compared to analyst estimates of $10.56 million. On average, sell-side analysts predict that Simulations Plus, Inc. will post 0.57 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 1st. Investors of record on Monday, January 25th were issued a $0.06 dividend. This represents a $0.24 annualized dividend and a yield of 0.33%. The ex-dividend date of this dividend was Friday, January 22nd. Simulations Plus’s payout ratio is 42.86%.

In other Simulations Plus news, Director Walter S. Woltosz sold 24,000 shares of Simulations Plus stock in a transaction on Wednesday, December 23rd. The shares were sold at an average price of $72.71, for a total transaction of $1,745,040.00. Following the sale, the director now owns 4,659,614 shares of the company’s stock, valued at approximately $338,800,533.94. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director David L. Ralph sold 5,000 shares of the company’s stock in a transaction on Monday, November 30th. The stock was sold at an average price of $55.65, for a total transaction of $278,250.00. Following the sale, the director now directly owns 16,581 shares of the company’s stock, valued at approximately $922,732.65. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 84,251 shares of company stock valued at $6,192,574. 24.45% of the stock is owned by company insiders.

A number of research analysts have issued reports on SLP shares. Zacks Investment Research upgraded Simulations Plus from a “sell” rating to a “hold” rating in a research report on Wednesday, January 13th. Taglich Brothers upgraded shares of Simulations Plus from a “speculative buy” rating to a “buy” rating and set a $76.00 target price for the company in a research note on Wednesday, November 25th. TheStreet upgraded shares of Simulations Plus from a “c+” rating to a “b” rating in a research report on Friday, January 8th. Oppenheimer upped their price objective on shares of Simulations Plus from $79.00 to $85.00 in a research report on Tuesday, January 12th. Finally, Craig Hallum lowered shares of Simulations Plus from a “buy” rating to a “hold” rating in a research note on Tuesday, January 12th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $81.60.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation, and prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments; and MembranePlus, which simulates laboratory experiments.

Recommended Story: How is the S&P 500 index different from the DJIA?

Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus, Inc. (NASDAQ:SLP).

Institutional Ownership by Quarter for Simulations Plus (NASDAQ:SLP)

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.